Associate Professor, Genetics - GIDP, Associate Professor, Molecular and Cellular Biology, Associate Professor, BIO5 Institute
Associate Professor, BIO5 Institute, Associate Professor, Chemistry and Biochemistry-Sci
Assistant Professor, BIO5 Institute, Assistant Professor, Neuroscience - GIDP, Assistant Professor, Pharmacology, Member of the Graduate Faculty
Dr. Khanna has worked in the areas of RNA, RNA-protein, and protein-protein interactions for over 10 years. Dr. Khanna's has a background in chemistry, structural biology, biophysics and drug discovery in neurodegenerative diseases. In her laboratory, she hsa several exciting ongoing projects that all focus on drug discovery using small molecules, peptides and aptamers. The Khanna laboratory develops inhibitors for difficult to target RNA-protein and protein-protein interfaces.
Assistant Professor, BIO5 Institute, Assistant Professor, Chemistry and Biochemistry - Med, Assistant Professor, Chemistry and Biochemistry-Sci
The Marty Lab uses mass spectrometry to study interactions of membrane proteins, peptides, and lipids within nanoscale membrane mimetics.
Professor, Applied Mathematics - GIDP, Professor, BIO5 Institute, Professor, Cancer Biology - GIDP, Professor, Genetics - GIDP, Professor, Molecular and Cellular Biology, Professor, Chemistry and Biochemistry-Sci
We investigate how proteins work in healthy organisms and how they fail in disease. We determine the atomic structures of proteins and the underlying biochemistry that gives rise to protein function. We also develop new proteins as drug targets for treating cancer and cardiovascular disease.
Associate Professor, BIO5 Institute, Associate Professor, Ecology and Evolutionary Biology, Associate Professor, Entomology, Associate Professor, Entomology / Insect Science - GIDP, Associate Professor, Genetics - GIDP, Associate Professor, Molecular and Cellular Biology, Associate Professor, Neuroscience - GIDP
Co-Director, Collaboratory for Anti-infectives & Therapeutics, Professor, Animal and Comparative Biomedical Sciences, Professor, BIO5 Institute, Professor, Immunobiology
Our research efforts focus on bacteria that cause serious healthcare-associated infections, and those associated with antibiotic use. This infections disproportiOur federally-funded research focuses on infection prevention. Specifically, we study diseases such as Clostridium difficile Infection that affect populations worldwide ("One-Health" issue). Our current efforts are aimed at translating bench-research findings to the bedside. We have recently been awarded two patents for a novel biologic agent invention aimed at preventing bacterial infections in humans as well as food animals.onately affect the elderly, and those with compromised immune systems. One overarching goal of our studies is to develop safe, cost-effective, non-antibiotic interventions to prevent and treat bacterial diarrheas.